Safety and Efficacy of IV Nerofe ™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer
Conditions: Metastatic Ovarian Cancer; Triple Negative Breast Cancer Intervention: Biological: Nerofe is a first in class derivative of a human hormon-peptide(TCApF), with Cancer suppressive properties. Sponsor: Immune System Key Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials